IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,420 | -17.5% | 14,182 | -8.8% | 0.00% | – |
| Q2 2023 | $143,499 | -18.9% | 15,547 | +20.8% | 0.00% | – |
| Q1 2023 | $176,875 | -20.2% | 12,873 | -1.2% | 0.00% | – |
| Q4 2022 | $221,572 | -21.7% | 13,026 | +4.8% | 0.00% | – |
| Q3 2022 | $283,000 | +32.9% | 12,429 | +5.1% | 0.00% | – |
| Q2 2022 | $213,000 | -20.8% | 11,823 | +17.7% | 0.00% | – |
| Q1 2022 | $269,000 | -15.4% | 10,048 | -7.4% | 0.00% | – |
| Q4 2021 | $318,000 | -55.0% | 10,849 | +1.0% | 0.00% | -100.0% |
| Q3 2021 | $706,000 | -23.7% | 10,740 | -3.4% | 0.00% | 0.0% |
| Q2 2021 | $925,000 | +6.8% | 11,121 | -1.5% | 0.00% | 0.0% |
| Q1 2021 | $866,000 | -8.6% | 11,292 | +5.2% | 0.00% | 0.0% |
| Q4 2020 | $948,000 | +19.7% | 10,734 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $792,000 | +1.4% | 10,734 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $781,000 | +84.6% | 10,701 | +42.2% | 0.00% | 0.0% |
| Q1 2020 | $423,000 | +46.4% | 7,527 | -0.5% | 0.00% | – |
| Q4 2019 | $289,000 | – | 7,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |